TELA Bio (TELA) Non Operating Income (2019 - 2026)
TELA Bio (TELA) posted Non Operating Income of -$1.9 million for Q2 2026, down 13.75% on a QoQ basis from -$1.7 million in Q1 2026, and down 137.21% year-over-year from $5.2 million in Q2 2025.
Analysis
TELA Bio (TELA) Non Operating Income (2019 - 2026) Analysis & Trends
TELA Bio has reported Non Operating Income for 8 years, with the latest figure at -$1.9 million in Q2 2026.
- On a quarterly basis, Non Operating Income fell 137.21% year-over-year to -$1.9 million in Q2 2026; TTM through Jun 2026 was -$6.9 million, a 94.23% decrease from a year earlier, with the FY2025 full-year figure at -$4.8 million, down 25.22% from the prior year.
- Non Operating Income was -$1.9 million for Q2 2026 at TELA Bio, down from -$1.7 million in the prior quarter.
- The five-year high for Non Operating Income was -$428000.0 in Q2 2023, with the low at -$2.5 million in Q2 2022.
- Average Non Operating Income over 5 years is -$1.1 million, with a median of -$1.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 165.25% in 2022, then soared 82.91% in 2023.
- Over 5 years, Non Operating Income stood at -$540000.0 in 2022, then retreated by 13.33% to -$612000.0 in 2023, then slumped by 63.07% to -$998000.0 in 2024, then slumped by 125.25% to -$2.2 million in 2025, then advanced by 14.64% to -$1.9 million in 2026.
- The last three Non Operating Income figures came in at -$1.9 million (Q2 2026), -$1.7 million (Q1 2026), and -$2.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | - |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | -12.30 Mn |
| 10 | TELA Bio | 50.24 Mn | 19.82 Mn | 13.94 Mn | -1.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.92 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -2.25 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -809,000.00 |
| Mar 31, 2025 | -740,000.00 |
| Dec 31, 2024 | -998,000.00 |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -835,000.00 |
| Dec 31, 2023 | -612,000.00 |
| Sep 30, 2023 | -776,000.00 |
| Jun 30, 2023 | -428,000.00 |
| Mar 31, 2023 | -773,000.00 |
| Dec 31, 2022 | -540,000.00 |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -2.50 Mn |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -965,000.00 |
| Sep 30, 2021 | -1.05 Mn |